Skip to main content

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Investor Investigation In Connection With March 18, 2015 Secondary Offering Announced

  • If you purchased shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in the March 18, 2015 Secondary Offering at $199.00 per share, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

April 1, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who purchased shares ofValeant Pharmaceuticals Intl Inc (NYSE:VRX) in the March 18, 2015 Secondary Offering at $199.00 per share, was announced concerning over potential securities laws violations in connection with the March 18, 2015 Secondary Offering. Shares of Valeant Pharmaceuticals Intl Inc (NYSE:...



You must register (for free) or login to view the entire investigation.